International Telepharmacy Education: Another Venue to Improve Cancer Care in the Developing World

被引:16
作者
AlFaar, Ahmad S. [2 ]
Kamal, Sherif [3 ]
AbouElnaga, Sherif [4 ]
Greene, William L. [5 ,6 ]
Quintana, Yuri [1 ]
Ribeiro, Raul C. [1 ,7 ]
Qaddoumi, Ibrahim A. [1 ,7 ]
机构
[1] St Jude Childrens Hosp, Int Outreach Program, Memphis, TN 38105 USA
[2] Childrens Canc Hosp, Dept Res, Cairo, Egypt
[3] Childrens Canc Hosp, Dept Pharmaceut Serv, Cairo, Egypt
[4] Childrens Canc Hosp, Dept Acad Affairs Res & Outreach, Cairo, Egypt
[5] St Jude Childrens Hosp, Dept Pharm, Memphis, TN 38105 USA
[6] St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA
[7] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA
关键词
pharmacy; distance learning; telemedicine; NEW-ZEALAND; SHORTAGE; PHARMACY; ONCOLOGY; WORKFORCE;
D O I
10.1089/tmj.2011.0182
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: In developed countries, pharmacists play a crucial role in designing and implementing cancer treatments as part of a multidisciplinary oncology team. However, developing countries have a shortage of pharmacists, and their role is generally limited to dispensing and selling drugs. The aim of this study was to investigate the feasibility of providing clinical pharmacy educational activities via international teleconferencing to improve cancer care in developing countries. Materials and Methods: Meticulous preparation and intense promotion of the workshop were done in Egypt before the telepharmacy conferences began. Multiple connectivity tests were performed to resolve technical problems. Nine telepharmacy conferences were delivered during 3-h sessions that were held on three consecutive days. Talks were subsequently made available via Web streaming. Attendees were requested to complete a survey to measure their satisfaction with the sessions. Results: The teleconference was attended by a total of 345 persons, and it was subsequently reviewed online via 456 log-in sessions from 10 countries. Technical issues (e. g., poor auditory quality) were resolved on the first day of the event. The rate of attendees' responses on the survey was 30.1%, and satisfaction with the event was generally good. Conclusions: Telecommunication is a relatively inexpensive approach that may improve pharmacy practices, especially those used to treat patients with cancer in developing countries. Special attention to patient-based telepharmacy education, including the use of cost-effective technology, should be considered.
引用
收藏
页码:470 / 474
页数:5
相关论文
共 16 条
  • [1] Anderson Stuart, 2002, J Interprof Care, V16, P391, DOI 10.1080/1356182021000008337
  • [2] The role of pharmacists in developing countries: the current scenario in Pakistan
    Azhar, Saira
    Hassali, Mohamed Azmi
    Ibrahim, Mohamed Izham Mohamed
    Ahmad, Maqsood
    Masood, Imran
    Shafie, Asrul Akmal
    [J]. HUMAN RESOURCES FOR HEALTH, 2009, 7
  • [3] Specializing in pediatric hematology and oncology
    Beavers, M. Brooke
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (08) : 812 - 813
  • [4] Rural pharmacy in New Zealand: Effects of a compulsory externship on student perspectives and implications for workforce shortage
    Capstick, Stuart
    Beresford, Rosemary
    Gray, Andrew
    [J]. AUSTRALIAN JOURNAL OF RURAL HEALTH, 2008, 16 (03) : 150 - 155
  • [5] New Zealand rural primary health care workforce in 2005: More than just a doctor shortage
    Goodyear-Smith, Felicity
    Janes, Ron
    [J]. AUSTRALIAN JOURNAL OF RURAL HEALTH, 2008, 16 (01) : 40 - 46
  • [6] Teleoncology: current and future applications for improving cancer care globally
    Hazin, Ribhi
    Qaddoumi, Ibrahim
    [J]. LANCET ONCOLOGY, 2010, 11 (02) : 204 - 210
  • [7] Clinical Telehealth Across the Disciplines: Lessons Learned
    Jarvis-Selinger, Sandra
    Chan, Elmira
    Payne, Ryan
    Plohman, Kerenza
    Ho, Kendall
    [J]. TELEMEDICINE JOURNAL AND E-HEALTH, 2008, 14 (07): : 720 - 725
  • [8] Khanal Saval, 2010, J Oncol Pharm Pract, V16, P75, DOI 10.1177/1078155209337662
  • [9] Knapp K K, 1999, J Am Pharm Assoc (Wash), V39, P127